These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6598490)

  • 61. [Investigation on potassium metabolism in the central nervous system; distribution of potassium in the brain, cerebellum and spinal cord].
    SAHOVIC K; DRASKOCI M; MIHAILOVIC L
    Glasnik; 1955; (9):179-85. PubMed ID: 13241823
    [No Abstract]   [Full Text] [Related]  

  • 62. [Investigations on potassium metabolism in the central nervous system; distribution of potassium in the brain, cerebellum, and spinal cord in various pathological conditions].
    SAHOVIC K; DRASKOCI M; MIHAILOVIC L
    Glasnik; 1955; (9):211-9. PubMed ID: 13241827
    [No Abstract]   [Full Text] [Related]  

  • 63. [Investigations on potassium metabolism in the central nervous system; distribution of potassium in the brain, cerebellum, and spinal cord in uremia].
    SAHOVIC K; DRASKOCI M; MIHAILOVIC L
    Glasnik; 1955; (9):195-203. PubMed ID: 13241825
    [No Abstract]   [Full Text] [Related]  

  • 64. [Investigation of potassium metabolism in the central nervous system; distribution of potassium in the brain, cerebellum and spinal cord following nephrectomy in dogs].
    SAHOVIC K; MIHAILOVIC L; DRASKOCI M
    Glasnik; 1955; (9):205-9. PubMed ID: 13241826
    [No Abstract]   [Full Text] [Related]  

  • 65. [Central mechanisms of fatigue and chemotherapy].
    Laborit H; Topall G; Baron C; Henriet I
    Agressologie; 1981; 22(5):183-94. PubMed ID: 6117210
    [No Abstract]   [Full Text] [Related]  

  • 66. Foreword.
    Nakanishi T; Tamai I; Deguchi Y
    Biol Pharm Bull; 2018; 41(9):1322-1323. PubMed ID: 30175768
    [No Abstract]   [Full Text] [Related]  

  • 67. The separation of nitrogen-containing phosphate esters from brain and spinal cord by ion-exchange chromatography.
    BAKER RW; PORCELLATI G
    Biochem J; 1959 Dec; 73(4):561-6. PubMed ID: 13796034
    [No Abstract]   [Full Text] [Related]  

  • 68. [Study of resorption, distribution, and elimination of Halidor using labelled Halidor].
    Blaskó K; Nagy J
    Acta Pharm Hung; 1968 Jun; 38(2):91-7. PubMed ID: 5749328
    [No Abstract]   [Full Text] [Related]  

  • 69. [Resorption experiments with a diphenylpropylamine].
    Leszkovszky G; Tardos L
    Acta Pharm Hung; 1968 Jun; 38(2):198-203. PubMed ID: 5723268
    [No Abstract]   [Full Text] [Related]  

  • 70. Oral overdose of propylhexedrine.
    Riddick L; Reisch R
    J Forensic Sci; 1981 Oct; 26(4):834-9. PubMed ID: 6117600
    [No Abstract]   [Full Text] [Related]  

  • 71. Escitalopram block of hERG potassium channels.
    Chae YJ; Jeon JH; Lee HJ; Kim IB; Choi JS; Sung KW; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):23-32. PubMed ID: 24045971
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats.
    Schaefer TL; Grace CE; Skelton MR; Graham DL; Gudelsky GA; Vorhees CV; Williams MT
    ACS Chem Neurosci; 2012 Jan; 3(1):12-21. PubMed ID: 22582138
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
    Benmansour S; Owens WA; Cecchi M; Morilak DA; Frazer A
    J Neurosci; 2002 Aug; 22(15):6766-72. PubMed ID: 12151556
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats.
    Kugelberg FC; Apelqvist G; Carlsson B; Ahlner J; Bengtsson F
    Br J Pharmacol; 2001 Apr; 132(8):1683-90. PubMed ID: 11309239
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain.
    Chaput Y; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):342-8. PubMed ID: 3022157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Milne RJ; Goa KL
    Drugs; 1991 Mar; 41(3):450-77. PubMed ID: 1711447
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Distribution of citalopram in the blood serum and in the central nervous system of rats after single and multiple dosage.
    Melzacka M; Rurak A; Adamus A; Daniel W
    Pol J Pharmacol Pharm; 1984; 36(6):675-82. PubMed ID: 6598490
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of some antidepressant drugs on apomorphine concentration in the central nervous system of rats and apomorphine-induced stereotypy.
    Rurak A; Melzacka M
    Pol J Pharmacol Pharm; 1985; 37(4):509-15. PubMed ID: 3866221
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.